Managing investments in biotechnology that is on the frontline area of science with immense potential for the benefit of human kind. Bio-Tech Ventures devotes wholly to achieve excellence in the development of next level biotechnology and especially high-profile teams of researchers. 

We also aim at realizing full potential of artificial intelligence applied in immunology and biotechnology as a whole. Bio-Tech Ventures Management is selecting promising R&D start-ups and investment targets with a well balanced risk-return profile for a portfolio that provides yield and creates value.

It's a Biotechnology investment vehicle focused at R&D and venture capital funding with comprehensive approach and focus on future break-through technologies.

We target early-stage companies that have huge potential to transform their markets and industries with real innovation behind them. Start-ups are usually at the very beginning of their journey when we approach them, and later we benefit from the potential that early-stage investments provide to the investor. Our Bio-Tech Ventures scientific team has vast experience in biotechnology and medicine, at the same time we have more than 20 years of experience in investment and finance, so we can consider our investment goals from both sides - scientific and investment at a professional level.

One of our main benefit is that we combine the best parts from traditional venture capital firms and R&D professionals. Like in traditional VCs our team is aimed at attracting investors who provide capital and a general management with extensive experience in investment and deep scientific knowledge of biotech, who will be supervising both capital and R&D activities.

At the same time we understand the market and have a successful experience of bio-tech operating businesses, as it is typical for corporate venture capital firms. Consequently we are capable of combining both investment and operational approach.

Personalized treatment is the future of humankind medical care. This could be achieved at a crossing of biology and technology in their widest sense. 

Bio-Tech Ventures has strong scientific background and vast experience in investments. This allows us to carefully screen and find perfect targets on biotech and medical care market and make a perfect match. Additionally the team has significant expertise in bringing high tech products to the market. This allows projects to have full external advise and support on the stages of marketing and clinical trials.

R&D teams can significantly improve, accelerate or reduce both cost and time of their research and clinical trials using one of the existing resources of our in-house Neural Network (Artificial Intelligence) platform. This allow for significant acceleration of development of a start-up and creation of additional synergies that will lead to an increased valuation.

In addition to that we mainly select start-ups with a synergistic effect for projects already existing in our portfolio. This multiplies capitalization of each of these companies and enhances the overall quality of our artificial intelligence software by additionally training it.